Charles Taunt, DO
Adult Reconstructive Orthopaedic Surgery · Lansing, MINPI 1104816511
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $81,346 of the $126,431 with a category attached, or 64.3%. Aesculap Implant Systems, LLC accounts for 91.3% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2019 at $45,162 and has fallen 99.0% since, to $440 in 2025.
Across 146 payments — averaging $865.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aesculap Implant Systems, LLC$115K
- Zimmer Biomet$6K
- Aesculap AG$2K
- Stryker$657
- Orthalign Inc$362
- Abbott$306
- plus $2K from 27 others
Across 1 payment — averaging $1150.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aesculap Implant Systems, LLC$1K
What the payments were for
- Consulting fees$81,34664%
- Speaking & faculty fees$5,5954%
- Travel & lodging$33,54227%
- Food & beverage$5,9485%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aesculap Implant Systems, LLC | 55 | $115,444 |
| Zimmer Biomet | 15 | $5,855 |
| Aesculap AG | 5 | $1,591 |
| Stryker | 7 | $657 |
| Orthalign Inc | 2 | $362 |
| Abbott | 3 | $306 |
| Linkbio Corp | 1 | $271 |
| Heron Therapeutics, Inc. | 4 | $262 |
| Amgen | 3 | $255 |
| Pacira Therapeutics, Inc. | 11 | $184 |
| Smith+Nephew | 3 | $142 |
| Solventum Corporation | 1 | $124 |
| Medacta USA, Inc. | 3 | $119 |
| Lima USA, Inc. | 1 | $113 |
| Omnilife Science, Inc | 1 | $83 |
| Ferring Pharmaceuticals Inc. | 5 | $82 |
| Medtronic | 1 | $77 |
| Boston Scientific | 1 | $63 |
| Orthofix Medical, Inc. | 3 | $59 |
| Johnson & Johnson(2 entities) | 3 | $59 |
| Arthrosurface Incorporated | 1 | $44 |
| Fidia Pharma USA Inc. | 2 | $37 |
| Davol Inc. | 1 | $28 |
| Radius Health, Inc. | 2 | $28 |
| Spinesmith Holdings, LLC | 1 | $26 |
| Bioventus LLC | 2 | $25 |
| Pfizer | 2 | $25 |
| Melinta Therapeutics, LLC | 2 | $23 |
| Dynasplint Systems Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Electronic Waveform Lab, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NO CURRENT MARKETED PRODUCT NAME$36,547
- Product Under Development - None$19,125
- ORTHOPILOT$8,928
- VEGA SYSTEM$5,768
- ROSA$4,750
- NO MARKETED PRODUCT NAME$4,084
- COLUMBUS CR$1,500
- COLUMBUS AS$807
- AS VEGA SYSTEM PS$625
- MAKO$366
- PROCLAIM$277
- ORTHALIGN PLUS$274
- INBONE$170
- INVISION$170
- PROPHECY$170
- ENDURO AS$142
- V.A.C. VERAFLO$124
- PREVENA$124
- EVENITY$122
- Zynrelef$121
How this compares
$126,431 in reported general payments places this provider in the 85th percentile of 35 adult reconstructive orthopaedic surgery providers in Michigan.
See all adult reconstructive orthopaedic surgery providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 161 | $2,845 |
| Mupirocin | 353 | $2,165 |
| Cephalexin | 332 | $1,396 |
| Minocycline Hcl | 22 | $491 |
| Oxycodone Hcl | 21 | $365 |
| Gabapentin | 37 | $287 |
| Clindamycin Hcl | 52 | $187 |
| Meloxicam | 52 | $180 |
| Ciprofloxacin Hcl | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Lansing
- Daniel MeskoLansing$99K
- Jason CochranLansing$9K
- John MeskoLansing$2K
- Michael MasiniYpsilanti$6.3M
- Jeffrey DeclaireRochester$5.4M
- Trevor BankaDetroit$339K
- Timothy EkpoGrand Blanc$295K
- Nicholas FrischAuburn Hills$244K
- Brian de BeaubienSaginaw$117K
- Anthony GemayelFlint$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.